CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 11 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $205 | -40.1% | 580 | +0.2% | 0.00% | – |
| Q2 2023 | $342 | +4.3% | 579 | +0.7% | 0.00% | – |
| Q1 2023 | $328 | -14.4% | 575 | +0.2% | 0.00% | – |
| Q4 2022 | $383 | -61.7% | 574 | +0.3% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 572 | +1.8% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 562 | +0.9% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 557 | +0.7% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 553 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 553 | -0.4% | 0.00% | – |
| Q2 2021 | $3,000 | -88.0% | 555 | -84.3% | 0.00% | – |
| Q1 2021 | $25,000 | +525.0% | 3,542 | +572.1% | 0.00% | – |
| Q4 2020 | $4,000 | +100.0% | 527 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 527 | +4.4% | 0.00% | – |
| Q2 2020 | $2,000 | – | 505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 458,466 | $1,783,000 | 0.72% |
| Affinity Asset Advisors, LLC | 400,000 | $1,548,000 | 0.56% |
| Sio Capital Management, LLC | 422,598 | $1,644,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,977,000 | 0.22% |
| Ikarian Capital, LLC | 99,422 | $385,000 | 0.06% |
| PURA VIDA INVESTMENTS, LLC | 102,324 | $398,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 322,373 | $1,254,000 | 0.01% |
| NEXT Financial Group, Inc | 23,852 | $93,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $895,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 67,600 | $263,000 | 0.00% |